Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology–Systemic Combination Therapy.

Saved in:
Bibliographic Details
Title: Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology–Systemic Combination Therapy.
Authors: Maruta, Susumu1 (AUTHOR) gunracketm@yahoo.co.jp, Koshima, Yohei1,2 (AUTHOR), Debari, Yuji1 (AUTHOR), Sugihara, Chihei1 (AUTHOR), Takahata, Gou1 (AUTHOR), Tamura, Ryo1 (AUTHOR), Ohshima, Tadashi1 (AUTHOR), Ono, Yuji1 (AUTHOR), Morita, Yuho1 (AUTHOR), Chiba, Tomoki1 (AUTHOR), Ishida, Satoru1 (AUTHOR), Imai, Hideto1 (AUTHOR), Watanabe, Keisuke1 (AUTHOR), Chinzei, Ryo1 (AUTHOR), Takahashi, Masanori1 (AUTHOR), Ooka, Yoshihiko2 (AUTHOR)
Source: Current Oncology. May2026, Vol. 33 Issue 5, p286. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol33050286